Vancouver, British Columbia — January 27, 2026 — Leads & Copy — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is targeting the global digital health diagnostics market with its AI-powered voice analysis technology for drug and alcohol intoxication detection.
The biotechnology company has developed a tool that analyzes voice data to predict drug and alcohol intoxication. MindBio’s technology uses machine learning models developed during clinical trials. The company says that the voice is a biomarker that can assess internal health and disease states.
MindBio is showcasing its technology in the USA. The core technology can reliably predict intoxication with hallucinogens and alcohol by analyzing voice. The company plans to expand its algorithms to detect other prohibited drugs. These drugs are often difficult to detect at scale and volume and require specialized equipment, according to MindBio.
The voice analytics solution is a innovation for intoxication detection in workplace environments, especially where drug and alcohol testing is mandated by regulators. Industries like mining, aviation, and construction, where high-volume testing for various drugs and alcohol presents challenges, could benefit from the technology. MindBio says the current testing methods are time-consuming and expensive.
MindBio says that its AI model uses over 50 million data points to predict alcohol intoxication with accuracy, estimating blood alcohol concentration levels using only the human voice.
The company is developing an enterprise version and new platform level technology for health prediction using the human voice and is expanding its drug and alcohol intoxication technology for use in workplace environments, call centres, mental health and law enforcement .
MindBio’s CEO Justin Hanka said the digital health diagnostics market represents a significant opportunity for MindBio to leverage its diagnostics technology with a first-mover advantage in speech analytics for drug and alcohol intoxication detection.
MindBio Therapeutics Corp. has been conducting drug and alcohol research and creating health prediction technologies using AI and machine learning for several years. The company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication. They are developing a comprehensive enterprise platform using voice and AI for detecting drug and alcohol intoxication in workplaces, law enforcement, mental health, and telehealth.
Source: MindBio Therapeutics
